BLACK WEEK DEAL 50% off all yearly plans. 🔥 See what we offer →

Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

fiercepharma.com

FiercePharma

Get the latest updates from FiercePharma directly as they happen.

Follow now 384 followers

Latest posts

Last updated 3 days ago

Vaccine-focused Valneva consolidates R&D footprint by shuttering site, eliminating 30 roles

3 days ago

French vaccine maker Valneva is closing down a site that houses both...

Medicare unveils price reductions for 15 drugs, including Novo's semaglutide

3 days ago

The U.S. has revealed price reductions for the second round of prescription...

In crowded kidney disease space, Otsuka receives FDA approval for first-in-class Voyxact

3 days ago

A new FDA approval for a first-in-class drug has vaulted Otsuka into...

Novo cashes in FDA national priority voucher for extra-speedy review of high-dose Wegovy

3 days ago

The company filed its bid for a 7.2 mg Wegovy formulation using...

French authorities raid Sanofi headquarters in tax fraud probe

3 days ago

More than 30 agents conducted a surprise raid of Sanofi’s headquarters in...

AZ's Imfinzi expands perioperative prowess into early-stage stomach cancer with FDA nod

3 days ago

The FDA signed off on Imfinzi as the first immunotherapy that can...

Ready-to-Use Vial Solutions: Driving Efficiency and Compliance to Support Biologics Production

4 days ago

Adopting an RTU vial setup for aseptic filling process can help optimize...

Calling all rising stars in pharma marketing: Nominations open for Fierce feature series

4 days ago

Nominate up-and-coming early-career pharma marketing pros here to be featured in Fierce's...

Advocacy, access and the future of cancer care take center stage in new Health Matters episode

4 days ago

ACS CAN’s Pam Traxel joins Health@WPP’s Wendy Lund to unpack what patients...

Sarepta gets FDA's go-ahead to study immunosuppressive Elevidys regimen in bid to reverse label restriction

4 days ago

Sarepta will study its gene therapy Elevidys with the immunosuppressant sirolimus in...

AbbVie short film showcases ‘Second Winds’ of life after CLL diagnosis

4 days ago

A short film that premiered earlier this month tracks the journeys of...

Pharma pros skeptical of letting AI loose on regulatory compliance submissions: survey

4 days ago

A survey has found that pharma marketing and promotional review professionals are...